An Alternative to the USP Disintegration Test for Orally Disintegrating Tablets - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

An Alternative to the USP Disintegration Test for Orally Disintegrating Tablets
The authors propose an alternative to the USP disintegration test method. The method embraces physiological conditions of the oral cavity, as a screening tool for developing ODT products.


Pharmaceutical Technology
Volume 32, Issue 8

Methods

Preparation of Covidien ODTs. Covidien (Mansfield, MA) ODT placebo granules consist of four components described in the "Materials" section. The granules were prepared by using a top-spray fluid-bed granulation process. The ODT placebo granules were mixed with 1.0% (w/w) sodium stearyl fumarate in a V-blender for 5 min. The lubricated placebo granules were then made into placebo tablets for disintegration comparison or used for preparing ODTs containing a high dose of acetaminophen (APAP). The APAP-containing tablets were prepared by the following steps:

  • Blend ODT placebo granules with taste-masked APAP granules in a V-blender for 20 min
  • Add 1.0% (w/w) sodium stearyl fumarate as the lubricant to the powder blend from the first step and then mix for additional 5 min in the blender
  • Compress the powder blend from the previous step to making tablets using a 16-station Manesty Betapress. The precompression force was 1300 N, and the main compression forces were 7 kN and 13 kN, respectively, at 60 rpm in 0.4062 and 0.5625-in. dies with round, flat-faced punches with beveled edges. The resulting tablet weights were targeted at 400 mg and 900 mg, respectively. For 900-mg tablets, the amount of APAP is shown in Table II.

Hardness test. The tablet crushing load, which is the force (kilopond, kp) required to break a tablet into halves by compression in the diametrical direction, was measured with a hardness tester (Varian Hardness Tester, VK-200).

Friability test. The friability test method was performed using a Varian Friabilator according to the USP 25 tablet friability method described in General Chapter ‹1216› Tablet Friability.

Evaluation of disintegration times

In vitro test using the USP disintegration method (5). The disintegration times of the Covidien 400 mg and 900 mg APAP-containing ODTs and representative commercial ODT products were determined according to the USP 29, test number 701 (5). The disintegration time was determined when the last tablet fully disintegrated and all particles passed through the screen.


Table I: Optimum volume of the blue dye solution for a given tablet size.
Simulated wetting test (13). The wetting time of the ODTs was evaluated using the method described below. The method is called the "Simulated Wetting Test" (SWT). One Whatman filter paper disk (21 mm in diameter) was placed in each well of a Corning 12-well polystyrene microplate (22 mm in diameter). A given volume (see Table I) of 0.1% (w/w) Sensient Blue #1 dye solution was then added into each well in various amounts based on tablet size using an automatic pipettor. An ODT was carefully placed on the surface of the wet paper disk in each well using a pair of forceps. The flat tablet face was in contact with the filter paper, and the level of the dye solution did not cover the tablet. The total wetting time was measured, defined as the time required for the blue dye solution to diffuse through the tablet and completely cover the surface. The wetting time was recorded as the simulated disintegration time.

Limited in vivo disintegration test in the mouth. An in vivo test of 900-mg placebo ODTs was conducted on four volunteers (three volunteers for 400-mg placebo ODTs). Each volunteer received 10 900-mg placebo ODTs, or 10 400-mg placebo ODTs, respectively. A placebo ODT was placed on the tongue of a volunteer, and the time for disintegration was measured by using a stopwatch. The ages of volunteers were between 20 and 60 years old. The participants were allowed to move the ODT against the upper roof of the mouth with their tongues and to cause gentle movement on the tablet without chewing it or tumbling the tablet from side to side. Immediately after the tablet disintegrated completely into small particles, the stopwatch was stopped and the time recorded. Forty 900-mg tablets and 30 400-mg tablets were evaluated accordingly and the results were reported.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here